試す 金 - 無料
AYURVEDIC HOSPITAL CARE: WHY INSURERS PUSH BACK—AND HOW TO WIN CLAIMS
Mint Kolkata
|November 20, 2025
Over the past few years, a friend has undergone Ayurvedic treatment for fluctuating blood pressure at a Kerala hospital. The insurer had routinely covered a week of hospitalization, but this time rejected the claim, arguing the annual treatment appeared more like rest than medical necessity. Ayurvedic claims are becoming harder to get approved.
Ayurveda remains popular, especially for chronic, low-severity conditions such as hypertension, high cholesterol and arthritis. Severity often determines the treatment path—someone with mildly elevated creatinine may opt for Ayurveda alone or as a supplement, but higher levels may require dialysis.
The growing use of Ayurveda, especially for chronic low-severity illnesses, creates a unique challenge for insurers. Allopathic treatment for such conditions usually happens on an outpatient (OPD) basis, so insurers don’t pay for it. But Ayurvedic treatment for the same conditions often requires hospitalization— and insurers do pay for that. Such hospitalization may be repeated annually for long-term benefits. So, from an insurer's perspective, Ayurvedic hospitalization results in additional cost that they would not otherwise have borne.
このストーリーは、Mint Kolkata の November 20, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Kolkata からのその他のストーリー
Mint Kolkata
Did the people have a say in the making of the Constitution?
A new book, based on archival research, offers an original take on the framing of the Constitution as a participatory process
5 mins
November 22, 2025
Mint Kolkata
Global giants press for PLIs on aerospace components
Airbus, Boeing, Pratt & Whitney seek production-linked incentives like the one for drones
3 mins
November 22, 2025
Mint Kolkata
Diagnostics chains step up as weight-loss therapies take off
The anti-obesity wave has birthed a new growth engine for diagnostics, as labs curate tests for those undergoing therapies involving drugs such as Mounjaro and Wegovy.
1 mins
November 22, 2025
Mint Kolkata
Space startup Agnikul raises ₹150 crore
Aerospace startup Agnikul has raised ₹150 crore in a Series C round, two people familiar with the matter told Mint, after its earlier plan to raise up to $50 million failed to draw sufficient investor interest.
1 mins
November 22, 2025
Mint Kolkata
Road trippin' through the Deep South in the US
A road trip through Louisiana, Alabama and Tennessee reveals the weight of civil rights history and its contradictions in small-town America
4 mins
November 22, 2025
Mint Kolkata
Chip crunch hits laptops, budget smartphones
Atypical memory chip used in smartphones and laptops accounts for 10-15% of the cost of production.
1 mins
November 22, 2025
Mint Kolkata
It's a new day for labour as 4 codes kick in
FROM PAGE 16
3 mins
November 22, 2025
Mint Kolkata
Digital gold stumbles, ETFs sniff opportunity
Fund houses are promoting gold ETFs as secure, regulated, transparent
2 mins
November 22, 2025
Mint Kolkata
All you need is glove
It may seem like a soft target, I know, to go after a show that has received no positive reviews at all.
4 mins
November 22, 2025
Mint Kolkata
Rising stars of mixed-doubles table tennis
Diya Chitale and Manush Shah are the first Indians to qualify for the WTT Finals
4 mins
November 22, 2025
Listen
Translate
Change font size

